# Kennametal Inc: financial statements, quarterly

KMT · NYSE · CIK 55242 · [Industrials](/sectors/industrials.md) · fiscal year ends Jun 30

Pages: [Overview](/companies/kmt.md) · [Financials](/companies/kmt/financials.md) · [Filings](/companies/kmt/filings.md) · [Insiders](/companies/kmt/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/kmt/financials.md?period=annual).

## Income statement

| Line item | Unit | Q1 FY2024 (2023-09-30) | Q2 FY2024 (2023-12-31) | Q3 FY2024 (2024-03-31) | Q4 FY2024 (2024-06-30) | Q1 FY2025 (2024-09-30) | Q2 FY2025 (2024-12-31) | Q3 FY2025 (2025-03-31) | Q4 FY2025 (2025-06-30) | Q1 FY2026 (2025-09-30) | Q2 FY2026 (2025-12-31) | Q3 FY2026 (2026-03-31) | Q4 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [492](/filings/0000055242-24-000067.md) | [495](/filings/0000055242-25-000021.md) | [516](/filings/0000055242-25-000046.md) | [543 d](/filings/0001628280-26-056143.md) | [482](/filings/0001628280-25-049444.md) | [482](/filings/0001628280-26-005371.md) | [486](/filings/0001628280-26-031335.md) | [516 d](/filings/0001628280-26-056143.md) | [498](/filings/0001628280-25-049444.md) | [530](/filings/0001628280-26-005371.md) | [593](/filings/0001628280-26-031335.md) | [737 d](/filings/0001628280-26-056143.md) |
| Cost of revenue | $m | [330](/filings/0000055242-24-000067.md) | [356](/filings/0000055242-25-000021.md) | [363](/filings/0000055242-25-000046.md) | [372 d](/filings/0001628280-26-056143.md) | [331](/filings/0001628280-25-049444.md) | [337](/filings/0001628280-26-005371.md) | [330](/filings/0001628280-26-031335.md) | [371 d](/filings/0001628280-26-056143.md) | [343](/filings/0001628280-25-049444.md) | [356](/filings/0001628280-26-005371.md) | [385](/filings/0001628280-26-031335.md) | [303 d](/filings/0001628280-26-056143.md) |
| Gross profit | $m | [163](/filings/0000055242-24-000067.md) | [140](/filings/0000055242-25-000021.md) | [153](/filings/0000055242-25-000046.md) | [171 d](/filings/0001628280-26-056143.md) | [151](/filings/0001628280-25-049444.md) | [145](/filings/0001628280-26-005371.md) | [156](/filings/0001628280-26-031335.md) | [146 d](/filings/0001628280-26-056143.md) | [155](/filings/0001628280-25-049444.md) | [174](/filings/0001628280-26-005371.md) | [208](/filings/0001628280-26-031335.md) | [434 d](/filings/0001628280-26-056143.md) |
| Selling, general and administrative | $m | not reported | not reported | not reported | not reported | [112](/filings/0001628280-25-049444.md) | [109](/filings/0001628280-26-005371.md) | [104](/filings/0001628280-26-031335.md) | [106 d](/filings/0001628280-26-056143.md) | [113](/filings/0001628280-25-049444.md) | [116](/filings/0001628280-26-005371.md) | [124](/filings/0001628280-26-031335.md) | [126 d](/filings/0001628280-26-056143.md) |
| Operating income | $m | [45.1](/filings/0000055242-24-000067.md) | [28.5](/filings/0000055242-25-000021.md) | [35.2](/filings/0000055242-25-000046.md) | [61.4 d](/filings/0001628280-26-056143.md) | [36.0](/filings/0001628280-25-049444.md) | [31.7](/filings/0001628280-26-005371.md) | [44.1](/filings/0001628280-26-031335.md) | [31.4 d](/filings/0001628280-26-056143.md) | [37.6](/filings/0001628280-25-049444.md) | [52.7](/filings/0001628280-26-005371.md) | [79.4](/filings/0001628280-26-031335.md) | [303 d](/filings/0001628280-26-056143.md) |
| Interest expense | $m | [6.6](/filings/0000055242-23-000051.md) | [6.8](/filings/0000055242-24-000008.md) | [6.8](/filings/0000055242-24-000026.md) | [6.2 d](/filings/0001628280-26-056143.md) | [6.3](/filings/0001628280-25-049444.md) | [6.2](/filings/0001628280-26-005371.md) | [6.2](/filings/0001628280-26-031335.md) | [6.2 d](/filings/0001628280-26-056143.md) | [6.2](/filings/0001628280-25-049444.md) | [6.1](/filings/0001628280-26-005371.md) | [6.3](/filings/0001628280-26-031335.md) | [10.0 d](/filings/0001628280-26-056143.md) |
| Income tax | $m | [8.1](/filings/0000055242-24-000067.md) | [(2.0)](/filings/0000055242-25-000021.md) | [7.8](/filings/0000055242-25-000046.md) | [16.9 d](/filings/0001628280-26-056143.md) | [7.9](/filings/0001628280-25-049444.md) | [7.9](/filings/0001628280-26-005371.md) | [10.2](/filings/0001628280-26-031335.md) | [7.2 d](/filings/0001628280-26-056143.md) | [9.1](/filings/0001628280-25-049444.md) | [13.5](/filings/0001628280-26-005371.md) | [18.6](/filings/0001628280-26-031335.md) | [69.8 d](/filings/0001628280-26-056143.md) |
| Net income | $m | [30.1](/filings/0000055242-24-000067.md) | [23.1](/filings/0000055242-25-000021.md) | [19.0](/filings/0000055242-25-000046.md) | [37.2 d](/filings/0001628280-26-056143.md) | [22.1](/filings/0001628280-25-049444.md) | [17.9](/filings/0001628280-26-005371.md) | [31.5](/filings/0001628280-26-031335.md) | [21.6 d](/filings/0001628280-26-056143.md) | [23.3](/filings/0001628280-25-049444.md) | [33.9](/filings/0001628280-26-005371.md) | [58.2](/filings/0001628280-26-031335.md) | [227 d](/filings/0001628280-26-056143.md) |
| Diluted EPS | $ per share | [0.37](/filings/0000055242-24-000067.md) | [0.29](/filings/0000055242-25-000021.md) | [0.24](/filings/0000055242-25-000046.md) | not reported | [0.28](/filings/0001628280-25-049444.md) | [0.23](/filings/0001628280-26-005371.md) | [0.41](/filings/0001628280-26-031335.md) | not reported | [0.30](/filings/0001628280-25-049444.md) | [0.44](/filings/0001628280-26-005371.md) | [0.75](/filings/0001628280-26-031335.md) | not reported |
| Basic EPS | $ per share | [0.38](/filings/0000055242-24-000067.md) | [0.29](/filings/0000055242-25-000021.md) | [0.24](/filings/0000055242-25-000046.md) | not reported | [0.28](/filings/0001628280-25-049444.md) | [0.23](/filings/0001628280-26-005371.md) | [0.41](/filings/0001628280-26-031335.md) | not reported | [0.31](/filings/0001628280-25-049444.md) | [0.44](/filings/0001628280-26-005371.md) | [0.76](/filings/0001628280-26-031335.md) | not reported |

- Revenue: us-gaap:Revenues
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Gross profit: us-gaap:GrossProfit
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q1 FY2024 (2023-09-30) | Q2 FY2024 (2023-12-31) | Q3 FY2024 (2024-03-31) | FY2024 (2024-06-30) | Q1 FY2025 (2024-09-30) | Q2 FY2025 (2024-12-31) | Q3 FY2025 (2025-03-31) | FY2025 (2025-06-30) | Q1 FY2026 (2025-09-30) | Q2 FY2026 (2025-12-31) | Q3 FY2026 (2026-03-31) | FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [95.1](/filings/0000055242-23-000051.md) | [90.7](/filings/0000055242-24-000008.md) | [92.1](/filings/0000055242-24-000026.md) | [128](/filings/0000055242-25-000068.md) | [120](/filings/0000055242-24-000067.md) | [121](/filings/0000055242-25-000021.md) | [97.5](/filings/0000055242-25-000046.md) | [141](/filings/0001628280-26-056143.md) | [103](/filings/0001628280-25-049444.md) | [129](/filings/0001628280-26-005371.md) | [107](/filings/0001628280-26-031335.md) | [95.8](/filings/0001628280-26-056143.md) |
| Current assets | $m | [1,011](/filings/0000055242-23-000051.md) | [1,010](/filings/0000055242-24-000008.md) | [1,000](/filings/0000055242-24-000026.md) | [1,003](/filings/0000055242-25-000068.md) | [1,004](/filings/0000055242-24-000067.md) | [969](/filings/0000055242-25-000021.md) | [1,013](/filings/0000055242-25-000046.md) | [1,039](/filings/0001628280-26-056143.md) | [1,033](/filings/0001628280-25-049444.md) | [1,121](/filings/0001628280-26-005371.md) | [1,278](/filings/0001628280-26-031335.md) | [1,772](/filings/0001628280-26-056143.md) |
| Total assets | $m | [2,513](/filings/0000055242-23-000051.md) | [2,544](/filings/0000055242-24-000008.md) | [2,519](/filings/0000055242-24-000026.md) | [2,504](/filings/0001628280-26-056143.md) | [2,522](/filings/0001628280-25-049444.md) | [2,436](/filings/0001628280-26-005371.md) | [2,491](/filings/0001628280-26-031335.md) | [2,545](/filings/0001628280-26-056143.md) | [2,519](/filings/0001628280-25-049444.md) | [2,596](/filings/0001628280-26-005371.md) | [2,731](/filings/0001628280-26-031335.md) | [3,167](/filings/0001628280-26-056143.md) |
| Current liabilities | $m | [420](/filings/0000055242-23-000051.md) | [414](/filings/0000055242-24-000008.md) | [413](/filings/0000055242-24-000026.md) | [416](/filings/0000055242-25-000068.md) | [398](/filings/0000055242-24-000067.md) | [382](/filings/0000055242-25-000021.md) | [416](/filings/0000055242-25-000046.md) | [422](/filings/0001628280-26-056143.md) | [397](/filings/0001628280-25-049444.md) | [439](/filings/0001628280-26-005371.md) | [536](/filings/0001628280-26-031335.md) | [677](/filings/0001628280-26-056143.md) |
| Total liabilities | $m | [1,214](/filings/0000055242-23-000051.md) | [1,216](/filings/0000055242-24-000008.md) | [1,213](/filings/0000055242-24-000026.md) | [1,215](/filings/0000055242-25-000068.md) | [1,204](/filings/0000055242-24-000067.md) | [1,176](/filings/0000055242-25-000021.md) | [1,212](/filings/0000055242-25-000046.md) | [1,221](/filings/0001628280-26-056143.md) | [1,193](/filings/0001628280-25-049444.md) | [1,238](/filings/0001628280-26-005371.md) | [1,332](/filings/0001628280-26-031335.md) | [1,553](/filings/0001628280-26-056143.md) |
| Current portion of debt | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $m | [1,260](/filings/0000055242-23-000051.md) | [1,288](/filings/0000055242-24-000008.md) | [1,265](/filings/0000055242-24-000026.md) | [1,250](/filings/0000055242-25-000068.md) | [1,277](/filings/0000055242-24-000067.md) | [1,220](/filings/0000055242-25-000021.md) | [1,237](/filings/0000055242-25-000046.md) | [1,284](/filings/0001628280-26-056143.md) | [1,284](/filings/0001628280-25-049444.md) | [1,315](/filings/0001628280-26-005371.md) | [1,355](/filings/0001628280-26-031335.md) | [1,570](/filings/0001628280-26-056143.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Current portion of debt: not reported
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q1 FY2024 (2023-09-30) | Q2 FY2024 (2023-12-31) | Q3 FY2024 (2024-03-31) | Q4 FY2024 (2024-06-30) | Q1 FY2025 (2024-09-30) | Q2 FY2025 (2024-12-31) | Q3 FY2025 (2025-03-31) | Q4 FY2025 (2025-06-30) | Q1 FY2026 (2025-09-30) | Q2 FY2026 (2025-12-31) | Q3 FY2026 (2026-03-31) | Q4 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [25.7](/filings/0000055242-24-000067.md) | [62.6 d](/filings/0000055242-25-000021.md) | [75.2 d](/filings/0000055242-25-000046.md) | [114 d](/filings/0001628280-26-056143.md) | [45.7](/filings/0001628280-25-049444.md) | [55.2 d](/filings/0001628280-26-005371.md) | [28.8 d](/filings/0001628280-26-031335.md) | [78.6 d](/filings/0001628280-26-056143.md) | [17.5](/filings/0001628280-25-049444.md) | [55.1 d](/filings/0001628280-26-005371.md) | [(2.9) d](/filings/0001628280-26-031335.md) | [(73.7) d](/filings/0001628280-26-056143.md) |
| Capital expenditure | $m | [31.8](/filings/0000055242-24-000067.md) | [25.7 d](/filings/0000055242-25-000021.md) | [26.8 d](/filings/0000055242-25-000046.md) | [23.3 d](/filings/0001628280-26-056143.md) | [24.7](/filings/0001628280-25-049444.md) | [19.2](/filings/0001628280-26-005371.md) | [23.5](/filings/0001628280-26-031335.md) | [21.5 d](/filings/0001628280-26-056143.md) | [23.0](/filings/0001628280-25-049444.md) | [12.7](/filings/0001628280-26-005371.md) | [18.0](/filings/0001628280-26-031335.md) | [23.2 d](/filings/0001628280-26-056143.md) |
| Dividends paid | $m | [15.9](/filings/0000055242-24-000067.md) | [15.9 d](/filings/0000055242-25-000021.md) | [15.9 d](/filings/0000055242-25-000046.md) | [15.7 d](/filings/0001628280-26-056143.md) | [15.6](/filings/0001628280-25-049444.md) | [15.6 d](/filings/0001628280-26-005371.md) | [15.5 d](/filings/0001628280-26-031335.md) | [15.2 d](/filings/0001628280-26-056143.md) | [15.1](/filings/0001628280-25-049444.md) | [15.2 d](/filings/0001628280-26-005371.md) | [15.2 d](/filings/0001628280-26-031335.md) | [15.2 d](/filings/0001628280-26-056143.md) |
| Share repurchases | $m | [13.7](/filings/0000055242-24-000067.md) | [15.0 d](/filings/0000055242-25-000021.md) | [15.0 d](/filings/0000055242-25-000046.md) | [21.8 d](/filings/0001628280-26-056143.md) | [15.0](/filings/0001628280-25-049444.md) | [15.0 d](/filings/0001628280-26-005371.md) | [25.0 d](/filings/0001628280-26-031335.md) | [5.0 d](/filings/0001628280-26-056143.md) | [10.0](/filings/0001628280-25-049444.md) | [0.0 d](/filings/0001628280-26-005371.md) | [0.0 d](/filings/0001628280-26-031335.md) | [0.0 d](/filings/0001628280-26-056143.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q1 FY2023 (2022-09-30) | Q2 FY2023 (2022-12-31) | Q3 FY2023 (2023-03-31) | Q1 FY2024 (2023-09-30) | Q2 FY2024 (2023-12-31) | Q3 FY2024 (2024-03-31) | Q1 FY2025 (2024-09-30) | Q2 FY2025 (2024-12-31) | Q3 FY2025 (2025-03-31) | Q1 FY2026 (2025-09-30) | Q2 FY2026 (2025-12-31) | Q3 FY2026 (2026-03-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [82.2](/filings/0000055242-23-000051.md) | [81.2](/filings/0000055242-24-000008.md) | [81.3](/filings/0000055242-24-000026.md) | [80.7](/filings/0000055242-24-000067.md) | [80.1](/filings/0000055242-25-000021.md) | [79.8](/filings/0000055242-25-000046.md) | [78.7](/filings/0001628280-25-049444.md) | [78.4](/filings/0001628280-26-005371.md) | [77.7](/filings/0001628280-26-031335.md) | [76.8](/filings/0001628280-25-049444.md) | [77.1](/filings/0001628280-26-005371.md) | [77.8](/filings/0001628280-26-031335.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 76,219,022 at 2026-07-31, from the cover of the [10-K filed 2026-08-12](/filings/0001628280-26-056143.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:19 ET. No prices; not investment advice.